Neuroimmunology Laboratory Areas of Research
- Chemotherapy-Induced Neuropathy
- Chemotherapy-Induced Cognitive Impairments
- Chronic Pain
- Neuron-glial Interactions
The overall aim of the studies performed within these laboratories is to increase our understanding of the pathophysiology of cancer therapy-induced neurobehavioral toxicities, including neuropathic pain, depressed mood, cognitive dysfunction and fatigue. We then apply this newly-acquired knowledge to the rational design of novel interventions for alleviating symptom burden in patients with cancer.
REGISTRATION IS NOW OPEN
This unique, interdisciplinary platform offers cutting-edge discussion, inspiration toward innovative solutions, and the opportunity to shape the future of pain management. Pain sciences professionals from both clinical and basic sciences are welcome.
6.25 hours of Continuing Education credit will be awarded.
The Neuroimmunology Laboratories are part of the Department of Symptom Research. The laboratories house four well-funded and collaborating principal investigators who share space, equipment and ideas.
The Neuroimmunology Laboratories provide a highly interactive, collaborative, international and research-focused environment.